Conditional expression of the FTO gene product in rat INS-1 cells reveals its rapid turnover and a role in the profile of glucose-induced insulin secretion

Clinical Science

Volumn 120, Issue 9, 2011, Pages 403-413

  Russell, Mark A ^a   Morgan, Noel G ^b  

^a PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

^b UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

cell; Fat mass and obesity associated (FTO); Glucose induced insulin secretion; Signal transducer and activator of transcription 3 (STAT3); Ubiquitin proteasome

Indexed keywords

FTO GENE PRODUCT; GENE PRODUCT; GLUCOSE; HEMAGGLUTININ; PROTEASOME INHIBITOR; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BODY MASS; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC TRANSFECTION; HEMAGGLUTINATION; INSULIN RELEASE; INSULIN SYNTHESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; UBIQUITINATION;

ANIMALS; CELLS, CULTURED; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; PROTEINS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT3 TRANSCRIPTION FACTOR; TRANSFECTION;

EID: 79951775774     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20100416     Document Type: Article

References (32)

1. Rennie, K. L. and Jebb, S. A. (2005) Prevalence of obesity in Great Britain. Obes. Rev. 6, 11-12
2. Haworth, C. M., Plomin, R., Carnell, S. and Wardle, J. (2008) Childhood obesity: genetic and environmental overlap with normal-range BMI. Obesity 16, 1585-1590 (Pubitemid 351915111)
3. Stunkard, A. J., Harris, J. R., Pedersen, N. L. and McClearn, G. E. (1990) The body-mass index of twins who have been reared apart. N. Engl. J. Med. 322, 1483-1487
4. Farooqi, I. S. and O'Rahilly, S. (2005) Monogenic obesity in humans. Annu. Rev. Med. 56, 443-458
5. Frayling, T. M., Timpson, N. J., Weedon, M. N., Zeggini, E., Freathy, R. M., Lindgren, C. M., Perry, J. R., Elliott, K. S., Lango, H., Rayner, N. W. et al. (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889-894 (Pubitemid 46764279)
6. Dina, C., Meyre, D., Gallina, S., Durand, E., Korner, A., Jacobson, P., Carlsson, L. M., Kiess, W., Vatin, V., Lecoeur, C. et al. (2007) Variation in FTO contributes to childhood obesity and severe adult obesity. Nat. Genet. 39, 724-726
7. Scuteri, A., Sanna, S., Chen, W. M., Uda, M., Albai, G., Strait, J., Najjar, S., Nagaraja, R., Orru, M., Usala, G. et al. (2007) Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 3, e115
8. Scott, L. J., Mohlke, K. L., Bonnycastle, L. L.,Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U. et al. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341-1345 (Pubitemid 46871655)
9. Peeters, A., Beckers, S., Verrijken, A., Roevens, P., Peeters, P., Van Gaal, L. and Van Hul, W. (2008) Variants in the FTO gene are associated with common obesity in the Belgian population. Mol. Genet. Metab. 93, 481-484
10. van der Hoeven, F., Schimmang, T., Volkmann, A., Mattei, M. G., Kyewski, B. and Ruther, U. (1994) Programmed cell death is affected in the novel mouse mutant Fused toes (Ft). Development 120, 2601-2607 (Pubitemid 24268833)
11. Peters, T., Ausmeier, K. and Ruther, U. (1999) Cloning of Fatso (Fto), a novel gene deleted by the Fused toes (Ft) mouse mutation. Mamm. Genome 10, 983-986 (Pubitemid 29470939)
12. Gerken, T., Girard, C. A., Tung, Y. C., Webby, C. J., Saudek, V., Hewitson, K. S., Yeo, G. S., McDonough, M. A., Cunliffe, S., McNeill, L. A. et al. (2007) The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318, 1469-1472 (Pubitemid 350208961)
13. Jia, G., Yang, C. G., Yang, S., Jian, X., Yi, C., Zhou, Z. and He, C. (2008) Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO. FEBS Lett. 582, 3313-3319
14. Kirkpatrick, C. L., Marchetti, P., Purrello, F., Piro, S., Bugliani, M., Bosco, D., de Koning, E. J., Engelse, M. A., Kerr-Conte, J., Pattou, F. and Wollheim, C. B. (2010) Type 2 diabetes susceptibility gene expression in normal or diabetic sorted human α and β cells: correlations with age or BMI of islet donors. PLoS ONE 5, e11053
15. Welters, H. J., Oknianska, A., Erdmann, K. S., Ryffel, G. U. and Morgan, N. G. (2008) The protein tyrosine phosphatase-BL, modulates pancreatic β-cell proliferation by interaction with the Wnt signalling pathway. J. Endocrinol. 197, 543-552
16. Thomas, H., Senkel, S., Erdmann, S., Arndt, T., Turan, G., Klein-Hitpass, L. and Ryffel, G. U. (2004) Pattern of genes influenced by conditional expression of the transcription factors HNF6, HNF4α and HNF1β in a pancreatic β-cell line. Nucleic Acids Res. 32, e150
17. 2+ and insulin secretory responses of MIN6 pseudoislets. Diabetes 48, 1402-1408
18. Gey, G. O. and Gey, M. K. (1936) Maintenance of human normal cells in continuous culture: preliminary report; cultivation of mesoblastic tumors and normal cells and notes on methods of culture. Am. J. Cancer 27, 45-76
19. Wargent, E. T. (2009) The measurement of insulin secretion using pancreas perfusion in the rodent. Methods Mol Biol. 560, 203-219
20. Welters, H. J., Senkel, S., Klein-Hitpass, L., Erdmann, S., Thomas, H., Harries, L.W., Pearson, E. R., Bingham, C., Hattersley, A. T., Ryffel, G. U. and Morgan, N. G. (2006) Conditional expression of hepatocyte nuclear factor-1β, the maturity-onset diabetes of the young-5 gene product, influences the viability and functional competence of pancreatic β-cells. J. Endocrinol. 190, 171-181
21. Yang, Y., Kitagaki, J., Dai, R. M., Tsai, Y. C., Lorick, K. L., Ludwig, R. L., Pierre, S. A., Jensen, J. P., Davydov, I. V., Oberoi, P. et al. (2007) Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics. Cancer Res. 67, 9472-9481
22. Tung, Y. C., Ayuso, E., Shan, X., Bosch, F., O'Rahilly, S., Coll, A. P. and Yeo, G. S. (2010) Hypothalamic-specific manipulation of Fto, the ortholog of the human obesity gene FTO, affects food intake in rats. PLoS ONE 5, e8771
23. Gorogawa, S., Fujitani, Y., Kaneto, H., Hazama, Y., Watada, H., Miyamoto, Y., Takeda, K., Akira, S., Magnuson, M. A., Yamasaki, Y. et al. (2004) Insulin secretory defects and impaired islet architecture in pancreatic β-cell-specific STAT3 knockout mice. Biochem. Biophys. Res. Commun. 319, 1159-1170
24. Legry, V., Cottel, D., Ferrieres, J., Arveiler, D., Andrieux, N., Bingham, A.,Wagner, A., Ruidavets, J. B., Ducimetiere, P., Amouyel, P. and Meirhaeghe, A. (2009) Effect of an FTO polymorphism on fat mass, obesity, and type 2 diabetes mellitus in the French MONICA Study. Metab. Clin. Exp. 58, 971-975
25. Wing, M. R., Ziegler, J., Langefeld, C. D., Ng, M. C., Haffner, S. M., Norris, J. M., Goodarzi, M. O. and Bowden, D. W. (2009) Analysis of FTO gene variants with measures of obesity and glucose homeostasis in the IRAS Family Study. Hum. Genet. 125, 615-626
26. Andreasen, C. H., Stender-Petersen, K. L., Mogensen, M. S., Torekov, S. S., Wegner, L., Andersen, G., Nielsen, A. L., Albrechtsen, A., Borch-Johnsen, K., Rasmussen, S. S. et al. (2008) Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes 57, 95-101
27. Bennetts, J. S., Fowles, L. F., Butterfield, N. C., Berkman, J. L., Teasdale, R. D., Simpson, F. and Wicking, C. (2006) Identification and analysis of novel genes expressed in the mouse embryonic facial primordia. Front. Biosci. 11, 2631-2646
28. Gemma, C., Sookoian, S., Alvarinas, J., Garcia, S. I., Quintana, L., Kanevsky, D., Gonzalez, C. D. and Pirola, C. J. (2009) Maternal pregestational BMI is associated with methylation of the PPARGC1A promoter in newborns. Obesity 17, 1032-1039
29. Strathdee, G., Sim, A. and Brown, R. (2004) Control of gene expression by CpG island methylation in normal cells. Biochem. Soc. Trans. 32, 913-915
30. Gerich, J. E. (2002) Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? Diabetes 51 (Suppl. 1), S117-S121
31. von Mikecz, A. (2006) The nuclear ubiquitin-proteasome system. J. Cell. Sci. 119, 1977-1984
32. Hay, R. T. (2005) SUMO: a history of modification. Mol. Cell. 18, 1-12